Skip to main content
Tech.euFundingExplorerBeta

Whitelab Genomics

Developer of genomics medicines via technology powered by artificial intelligence (AI)

Whitelab Genomics has raised €33M across 2 funding rounds from 5 investors, most recently a Series B round in Oct 2026. Based in Paris, France; active in Healthtech. Data as of 28 Oct 2026.

Total raised
€33M
€33,028,010
Funding rounds
2
Investors
5
distinct backers
Active since
2022-09
latest 2026-10

Funding by year

EUR raised per year · 2026 YTD
Whitelab Genomics — funding by year — interactive chart.
Data table
Whitelab Genomics — funding by year
2022€9.8M
2026€23M

Signals

High confidence
Raise-next likelihood20
base rate 48% for Series B
  • ▼ Raised very recently
  • ▲ Up-round momentum
  • ▼ Low backer re-investment
Exit likelihood18
base rate 11% (2+ rounds)
  • ▲ €30M+ raised
  • ▲ Recently backed by strong-exit-track investors

Timing: too soon vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.

Funding rounds

2 rounds

Similar companies

same sector or country

Global coverage: FundingData